The emergence of new diseases, changes in lifestyle, social evolution, the complexity of technological resources as well as many other factors, makes research of new therapeutic solutions an ever pressing necessity.
By the 1990s, we began our Research and Development (R&D) project. In the last decade we saw the birth of our own medicines. We are building our way into research inspired by our strong motivation: Keeping life in mind.
The BIAL Group invests over 20% of its turnover in R&D. This is our major pledge: we are committed to discovering and developing innovative medicines.
Our R&D centre in Portugal is staffed by international teams of highly qualified people. It comprises chemists, pharmacologists, biochemists, physicians and pharmacists, all of whom are dedicated to finding new drugs, particularly in neurosciences.
Our scientific team centralizes all the areas involved in the process of finding new medicinal products: chemical, pharmacological and clinical investigation. We collaborate with investigators and scientists from universities, industry and research centers to deliver the best solutions to health professionals, patients and their families.
In recognition of BIAL's commitment to research and development, the group is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the respected federation of leading research firms in the European pharmaceutical sector.
BIAL takes responsibility for its website contents. By clicking “continue” below, you will be taken to an external website, beyond our responsibility.